Conversion to Complete Resection with mFOLFOX6 with Bevacizumab or Cetuximab Based on K ‐RAS Status for Unresectable Colorectal Liver Metastasis (BECK study): Long‐Term Results of Survival
ConclusionsConversion hepatectomy achieved a similar long ‐term survival to the results of previous studies in initially resectable patients, although many of them experienced several post‐hepatectomy recurrences. Left‐sided primary was found to be the predictor for conversion hepatectomy.
Source: Journal of Hepato-Biliary-Pancreatic Sciences - Category: Gastroenterology Authors: Masayuki Okuno,
Etsuro Hatano,
Rei Toda,
Hiroto Nishino,
Kojiro Nakamura,
Takamichi Ishii,
Satoru Seo,
Kojiro Taura,
Kentaro Yasuchika,
Takefumi Yazawa,
Masazumi Zaima,
Akiyoshi Kanazawa,
Hiroaki Terajima,
Satoshi Kaihara,
Yukihito Adachi,
Tags: ORIGINAL ARTICLE Source Type: research
More News: Avastin | Cancer | Cancer & Oncology | Colorectal Cancer | Erbitux | Gastroenterology | Liver | Pancreas | Pancreatic Cancer | Study | Urology & Nephrology